Immune responses to tuberculosis in developing countries: implications for new vaccines.
about
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDPrime-boost approaches to tuberculosis vaccine developmentA dynamic analysis of tuberculosis dissemination to improve control and surveillanceVariable host-pathogen compatibility in Mycobacterium tuberculosisThe TB pandemic: an old problem seeking new solutions.Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance.IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance.Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients.The immunology of tuberculosis: from bench to bedside.Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis.Perspectives on clinical and preclinical testing of new tuberculosis vaccines.Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive personsTorticollis in mice intravenously infected with Mycobacterium tuberculosis.Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.Interaction of Pattern Recognition Receptors with Mycobacterium TuberculosisImpact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients.The importance of adjuvant formulation in the development of a tuberculosis vaccine.Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming.The use of Quantiferon-TB gold in-tube test in screening latent tuberculosis among Saudi Arabia dialysis patients.Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.Confronting the scientific obstacles to global control of tuberculosis.Helminthes could influence the outcome of vaccines against TB in the tropics.Lethal interaction: the colliding epidemics of tobacco and tuberculosis.Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages.Lessons for tuberculosis vaccines from respiratory virus infection.A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.Unfolding the relationship between secreted molecular chaperones and macrophage activation states.Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.Pathology of post primary tuberculosis of the lung: an illustrated critical review.The pathology of Mycobacterium tuberculosis infection.Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance.Immunological mechanisms by which concomitant helminth infections predispose to the development of human tuberculosis.The granuloma in tuberculosis: dynamics of a host-pathogen collusion.Challenges and solutions for a rational vaccine design for TB-endemic regions.Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages.ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.
P2860
Q22241773-B16D1266-169E-4480-AFDF-DC227438B8BFQ27024526-4DD71A0B-DB23-4528-B538-1D3DDC7CFD2CQ27316245-5562FBF8-65DF-49AC-B5D4-A4918E61B1C6Q28768257-4E3DCC20-8953-47A1-8FCA-D32C62D6F511Q30360726-9AED0526-E8C8-4924-84B2-19594DDD3F3FQ30362107-D44FEDAA-E126-4DC2-B685-579337093383Q31131991-8C491A34-8E24-44C3-A437-2A47D1EAE378Q33770118-34F917BF-0903-4992-B556-1C13F2D3569BQ33777367-753C324D-B17C-4556-A26D-395133610FA7Q33900309-769275F4-B2D5-4206-A1DB-34E61D5D5578Q34189865-E849E774-DEF7-4CA7-9519-589BADDF1F46Q34202804-FD30AA0D-0611-4FB7-B44F-D6E93E3A7CC4Q34701378-E87BEBB8-5DA8-4337-AE52-7C90B4EEC3E1Q34840811-CF64D294-B530-4EA9-B50B-09EE4EC157E1Q34975770-29CCF197-49EE-42A4-B762-72DB61D8C838Q35014476-477C90CC-FF9B-4994-8DFF-F1F1DAA4F429Q35110073-0B0F768A-3B35-416B-AF10-C64212F9C5B6Q35783475-41CF06E0-CFF5-440C-9947-7C197397ACD7Q36094423-F736D674-D494-4BA7-A85E-08742CB336B2Q36298260-DBC24905-619C-4429-BAE0-35E98CDE4FB5Q36303272-C08D23CD-7559-4CB7-8A1C-C5360C8C7EC0Q36513366-6512221C-E77F-4DF6-8B09-7DC2AC19FE56Q36590688-D0601504-28E7-45A4-A3CD-C3B1BBCCA608Q36839707-6083061C-D869-4CB6-9617-35CBACCD427BQ37112790-D0C3257B-CF50-40EC-933B-97EF8CE8DA87Q37290093-053D120F-39A0-4E3D-B3E5-A272EC729E5AQ37301506-F94551D4-950A-4F7E-BFDB-315FA2F1CA0CQ37308827-BDC24A67-E813-4635-90B9-836730800D84Q37451207-268600AA-E8EE-4ED2-8523-19C8406D6D56Q37898308-31BEB251-30D0-433F-8024-2577A7DE7A15Q37977379-6F68F02C-3D8D-41D3-8B33-7589DCF30824Q38006597-C1FE20BB-D7BB-4DDF-8E14-0AA8A9743BFEQ38066471-3572FA73-992B-4718-832F-49D647CBB130Q38073249-8E64AD06-AF71-40EB-BA79-B781C58B9004Q38185119-127BAFE1-D004-4796-9FBB-E408EC4F8852Q39021341-654BDD98-EE6F-46CA-95AE-D71A80296296Q39153043-AD476AB4-8EAF-4A11-B18A-6BFB13D99CBCQ39373309-D527AB71-CDCE-4303-A9FB-C260BBEAAA0CQ39497862-5E3AB33E-999B-4BDC-B1D9-77D7CE36692EQ39552628-7B662AA4-BCC3-43ED-8491-A0EE46976C2A
P2860
Immune responses to tuberculosis in developing countries: implications for new vaccines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@ast
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@en
type
label
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@ast
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@en
prefLabel
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@ast
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@en
P2860
P356
P1476
Immune responses to tuberculosis in developing countries: implications for new vaccines.
@en
P2093
Graham A W Rook
P2860
P304
P356
10.1038/NRI1666
P577
2005-08-01T00:00:00Z